GlobalRPh Renal Dosing Masterv6.6
Source review / handoff

Daptomycin

One or two intact local summaries. No averaged regimen, patient-specific dose or automatic source preference.

Selecting here opens the current stored cards. The pinned link below records their fingerprints. Do not enter patient information in links or searches.

Share or print this source review

1 local source card selected. Local card fingerprints checked where supplied. This is not an original-document hash, source-currency guarantee or clinical approval. Record-level cautions below are the current library's cautions, not a frozen prior version.

Copy is optional; the link can be selected and copied manually. No patient data or dose decision is collected.

Clinical context remains essential

Independent clinical review is pending. Confirm indication, exact formulation/route, population, renal measure and units, kidney-function stability, dialysis prescription, interacting drugs, monitoring and source revision. An RX mirror and its original label are not independent corroboration. Missing disagreement notes do not certify agreement.

Check source scope before reading a dose

UCSF - daptomycin: high-dose institutional regimen

Product / population
Adults; source-specific institutional guidance. Match route, indication and renal replacement modality.
Renal method
CrCl in mL/min where specified; no equation inferred.
Source revision
Revision date not stated in the reviewed page.
Retrieved
2026-09-05
Local review status
Locally included source-specific summary. Regimen differences are not automatically resolved.

Documented differences and cautions on this drug

All record notes are retained here, including notes about sources not selected in this review.

Do not merge label and higher-dose institutional dialysis protocols

The label includes CrCl exactly 30 in its >=30 band. UCSF prints >30 and <30, omitting exactly 30, and uses higher doses and different HD scheduling.

What to reconcile: Keep source-specific dose, interval, indication, weight basis and modality together. The official threshold is explicit; seek institutional clarification rather than silently changing its headings.

Source-specific interpretation; independent clinician adjudication pending.

Open this note and its source references
Professional

UCSF - daptomycin: high-dose institutional regimen

Open original reference

UCSF Infectious Diseases Management Program · Adults; source-specific institutional guidance. Match route, indication and renal replacement modality.

Renal method: CrCl in mL/min where specified; no equation inferred.
Source date: Revision date not stated in the reviewed page.
Retrieved: 2026-09-05

Locally included source-specific summary. Regimen differences are not automatically resolved.

Dosing / renal protocol and limits

IV dosing at CrCl >30 mL/min is 8-10 mg/kg daily; below 30, 8-10 mg/kg every 48 hours. The webpage omits exactly 30. Certain VRE infections may require up to 12 mg/kg with ID pharmacy guidance.

IHD: 8-10 mg/kg initially and after HD; an unstable dialysis schedule may instead use every-48-hour dosing. CVVHD: 6-8 mg/kg daily. Flow above 2.5 L/hour can require higher dosing; obtain specialist input. This continuous regimen has not been evaluated for other modalities such as CVVH.

Weight is total body weight unless it exceeds 120% of ideal body weight, when UCSF uses adjusted weight. Daptomycin is not effective for pneumonia. These high-dose institutional recommendations remain distinct from label regimens.

RDM30-017-daptomycin-1 · Source locator: UCSF - daptomycin: high-dose institutional regimen; renal/dosing sections and stated qualifiers

Source identity and provenance
Source
https://idmp.ucsf.edu/content/daptomycin
Retrieved
2026-09-05
Renal-function method
CrCl in mL/min where specified; no equation inferred.
Source date/version
Revision date not stated in the reviewed page.
Hash meaning
Locally authored summary text; not original SPL, HTML or PDF bytes
Local summary SHA-256
3498e24eea55d29cd8ac79fc1a98e3285f46b4718a55d31db74ea2fbcf1c96a8

Document the clinical decision separately

This reference does not select a regimen. Complete the indication, measured/estimated renal function and trend, dialysis setting, source rationale, monitoring and reassessment plan in your institution's approved documentation system. Confirm the complete current source before adopting its regimen.

GlobalRPh v6.6 | RDM66-DIRECT-PHP-20260911 | Local library date 2026-09-11. Selected-card identity does not imply clinical verification.

Pinned reference: https://globalrph.com/blogCalcs/renal-dosing-master/compare.php?id=daptomycin&s1=RDM30-017-daptomycin&h1=122257f13f94c01e2a8f6ecdb4e99af9217f3c42938a385b577afe5c5360f0e9